uridine diphosphate glucuronic acid has been researched along with dasatinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamath, AV; Lee, FY; Marathe, PH; Wang, J | 1 |
1 other study(ies) available for uridine diphosphate glucuronic acid and dasatinib
Article | Year |
---|---|
Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Dasatinib; Dogs; Enzyme Inhibitors; Haplorhini; Hepatocytes; Humans; In Vitro Techniques; Intestinal Absorption; Macaca fascicularis; Mice; Mice, Knockout; Microsomes, Liver; NADH, NADPH Oxidoreductases; Protein Binding; Proto-Oncogene Proteins c-bcr; Pyrimidines; Rats; Species Specificity; src-Family Kinases; Thiazoles; Uridine Diphosphate Glucuronic Acid | 2008 |